Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial.
Journal Information
Full Title: Pediatr Infect Dis J
Abbreviation: Pediatr Infect Dis J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Communicable Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"M.G.J., J.L., F.-H.S., J.A.H., M.B., C.D.A., E.G.R. and C.J.B. are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ (MSD), who may own stock and/or hold stock options in the Merck & Co., Inc., Rahway, NJ. M.W.P. was an employee of MSD at the time of study conduct. E.R. reports grant funding and consulting fees from MSD to his institution. E.R., N.A., and J.S.B. report funding to conduct the study from MSD to their institutions."
"Funding for this research was provided by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025